Nebenwirkungen · Aldara
ALDARA 5% cream · Abschnitt 4.8 · PDF-Seite 10
HOS-088050 · Präparat HOS-083607
Remote site skin reactions, mainly erythema (44%), were also reported in the placebo controlled trials. These reactions were at non-wart sites which may have been in contact with imiquimod cream. Most skin reactions were mild to moderate in severity and resolved within 2 weeks of treatment discontinuation. However, in some cases these reactions have been severe, requiring treatment and/or causing incapacitation. In very rare cases, severe reactions at the urethral meatus have resulted in dysuria in women (see section 4.4).
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-07-18T11:40:00Z · SHA-256 29a2c6949b9e74d0aba2dc8c33290a7bc20b103110a06b748f4e53afb53b0ce7 · Passage 462c4cfcd2a356237e337970da5023e36387f22e1e0257a9338b590407c73157 · Zeichen 10263–10791 im Abschnitt